Methyl-β-Cyclodextrin Impairs the Monocyte-Adhering Ability of Endothelial Cells by Down-Regulating Adhesion Molecules and Caveolae and Reorganizing the Actin Cytoskeleton-Reference-Cited by-同舟云学术

Methyl-β-Cyclodextrin Impairs the Monocyte-Adhering Ability of Endothelial Cells by Down-Regulating Adhesion Molecules and Caveolae and Reorganizing the Actin Cytoskeleton

Published:2016 Issue:6 Volume:39 Page:1029-1034
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Ao Meiying¹²³,Wu Li⁴,Zhou Xing¹,Chen Yong¹³

Affiliation:

1. Nanoscale Science and Technology Laboratory, Institute for Advanced Study, Nanchang University

2. Department of Pharmacy, Science and Technology College, Jiangxi University of Traditional Chinese Medicine

3. College of Life Sciences, Nanchang University

4. School of Basic Medical Sciences, Jiangxi University of Traditional Chinese Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/39/6/39_b16-00047/_pdf

Reference28 articles.

1. 1) Davis ME, Brewster ME. Cyclodextrin-based pharmaceutics: Past, present and future. Nat. Rev. Drug Discov., 3, 1023–1035 (2004).

2. 2) Christian AE, Haynes MP, Phillips MC, Rothblat GH. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res., 38, 2264–2272 (1997).

3. 3) Zidovetzki R, Levitan I. Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies. Biochim. Biophys. Acta, 1768, 1311–1324 (2007).

4. 4) Mahammad S, Parmryd I. Cholesterol depletion using methyl-beta-cyclodextrin. Methods Mol. Biol., 1232, 91–102 (2015).

5. 5) Loftsson T, Duchene D. Cyclodextrins and their pharmaceutical applications. Int. J. Pharm., 329, 1–11 (2007).

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shear Stress and Sub-Femtomolar Levels of Ligand Synergize to Activate ALK1 Signaling in Endothelial Cells;Cells;2024-02-05

2. Cyclodextrins as therapeutic drugs for treating lipid metabolism disorders;Obesity Reviews;2024-01-10

3. Shear stress and very low levels of ligand synergize to activate ALK1 signaling in endothelial cells;2023-11-03

4. Oligosaccharides as Potential Therapeutics against Atherosclerosis;Molecules;2023-07-17

5. SR-BI regulates the synergistic mast cell response by modulating the plasma membrane-associated cholesterol pool;2023-06-24